Maret Estelle, Wiskott Kim, Shipley Tobias, Gilardi Federica, Augsburger Marc, Thomas Aurelien, Fracasso Tony, Sajic Tatjana
Faculty Unit of Toxicology, University Center of Legal Medicine, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Lausanne University Hospital and Geneva University Hospital, Lausanne, Vaud, Switzerland.
Proteomics Clin Appl. 2025 Mar;19(2):e202400022. doi: 10.1002/prca.202400022. Epub 2024 Dec 20.
Traumatic brain injury (TBI), including pediatric abusive head trauma (AHT), is the leading cause of death and disability in children and young adults worldwide. The current understanding of trauma-induced molecular changes in the brain of human subjects with intracranial hemorrhage (ICH) remains inadequate and requires further investigation to improve the outcome and management of TBI in the clinic. Calcium-mediated damage at the site of brain injury has been shown to activate several catalytic enzymes.
Serine hydrolases (SHs) are major catalytic enzymes involved in the biochemical pathways of blood coagulation, systemic inflammation, and neuronal signaling. Here, we investigated activity-based protein profiling (ABPP) coupled to liquid chromatography-mass spectrometry (LC-MS) by measuring the activity status of SH enzymes in the serum of infants with severe ICH as a consequence of AHT or atraumatic infants who died of sudden infant death syndrome (SIDS).
Our proof-of-principle study revealed significantly reduced physiological activity of dozens of metabolic SHs in the serum of infants with severe AHT compared to the SIDS group, with some of the enzymes being related to neurodevelopment and basic brain metabolism.
To our knowledge, this is the first study to investigate the ABPP of the SHs enzyme family to detect changes in their physiological activity in blood serum in severe TBI. We used antemortem (AM) serum from infants under the age of 2 years who were victims of AHT with a severe form of ICH. The analytical approach used in the proof-of-principle study shows reduced activities of serum serine lipases in AHT cases and could be further investigated in mild forms of AHT, which currently show 30% of misdiagnosed cases in clinics.
创伤性脑损伤(TBI),包括儿童虐待性头部创伤(AHT),是全球儿童和青年死亡和残疾的主要原因。目前对颅内出血(ICH)的人类受试者大脑中创伤诱导的分子变化的理解仍然不足,需要进一步研究以改善临床中TBI的治疗效果和管理。脑损伤部位的钙介导损伤已被证明可激活多种催化酶。
丝氨酸水解酶(SHs)是参与血液凝固、全身炎症和神经元信号传导生化途径的主要催化酶。在此,我们通过测量因AHT导致严重ICH的婴儿或死于婴儿猝死综合征(SIDS)的无创伤婴儿血清中SH酶的活性状态,研究了基于活性的蛋白质谱分析(ABPP)与液相色谱-质谱联用(LC-MS)。
我们的原理验证研究表明,与SIDS组相比,患有严重AHT的婴儿血清中数十种代谢性SHs的生理活性显著降低,其中一些酶与神经发育和基本脑代谢有关。
据我们所知,这是第一项研究SHs酶家族的ABPP以检测严重TBI患者血清中其生理活性变化的研究。我们使用了2岁以下因严重形式的ICH而成为AHT受害者的婴儿的死前(AM)血清。原理验证研究中使用的分析方法显示AHT病例中血清丝氨酸脂肪酶活性降低,并且可以在轻度形式的AHT中进一步研究,目前临床中此类病例有30%被误诊。